provider image
Welcome! You’re in GoodRx for healthcare professionals. Now, you’ll enjoy a streamlined experience created specifically for healthcare professionals.
Skip to main content
Incruse Ellipta Coupon - Incruse Ellipta 30 blisters of 62.5mcg inhaler

Incruse Ellipta

umeclidinium
Used for COPD
Used for COPD

Incruse Ellipta (umeclidinium) is an long-acting muscarinic antagonist (LAMA). It's an inhaler used for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults. Incruse Ellipta (umeclidinium) is inhaled through the mouth once per day. People who use Incruse Ellipta (umeclidinium) typically don't experience too many side effects, but ones reported include common cold symptoms, like sore throat and cough.

Last reviewed on June 25, 2024
basics-icon

What is Incruse Ellipta (umeclidinium)?

What is Incruse Ellipta (umeclidinium) used for?

How Incruse Ellipta (umeclidinium) works

Incruse Ellipta (umeclidinium) is a long-acting muscarinic antagonist (LAMA), a type of anticholinergic medication. It works by blocking a chemical called acetylcholine to relax the muscles in your airways.

Are you looking for information on Anoro Ellipta (umeclidinium / vilanterol) instead?

Drug Facts

Common BrandsIncruse Ellipta
Drug ClassLAMA
Controlled Substance ClassificationNot a controlled medication
Generic StatusNo lower-cost generic available
AvailabilityPrescription only

More on Incruse Ellipta (umeclidinium) essentials

coupon-save-icon

Get your GoodRx coupon

Avg retail price
$427.66(save 16.19%)
GoodRx discount
$358.41
See prices
basics-icon

What are the side effects of Incruse Ellipta (umeclidinium)?

The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.

Common Side Effects

Other Side Effects

  • Sore throat
  • Muscle pain
  • Fast heart beat

Serious Side Effects

Contact your healthcare provider immediately if you experience any of the following.
  • Serious allergic reaction: hives, swelling of your face, lips, or tongue, difficulty breathing
  • Sudden narrowing of your airways: difficulty breathing, wheezing, chest pain or tightness, cough

Source: DailyMed

The following side effects have also been reported

Side effects that you should report to your care team as soon as possible:

  • Allergic reactions—skin rash, itching, hives, swelling of the face, lips, tongue, or throat
  • Sudden eye pain or change in vision such as blurry vision, seeing halos around lights, vision loss
  • Trouble passing urine
  • Wheezing or trouble breathing that is worse after use

Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):

pros-and-cons

Pros and cons of Incruse Ellipta (umeclidinium)

thumbs-up

Pros

Inhaled once per day

Might be easier to use compared to some other dry powder inhalers

Can be stored at room temperature

thumbs-down

Cons

Can't use if you're severely allergic to milk proteins because it contains lactose

Not a rescue inhaler for sudden breathing problems

Brand-name medication only

pharmacist-tips

Pharmacist tips for Incruse Ellipta (umeclidinium)

pharmacist
  • Take an inhalation of Incruse Ellipta (umeclidinium) at the same time once per day to prevent COPD attacks. You can take Incruse Ellipta (umeclidinium) at any time of the day.

    • If you have sudden trouble breathing, use your rescue inhaler. Incruse Ellipta (umeclidinium) won't treat a COPD attack as it's happening.

      • Call your pulmonologist if your breathing or peak flow meter results worsen. Also contact your pulmonologist if you're using your rescue inhaler more often than usual. These could be signs that you need another long-acting medication to help manage your COPD.

        • Store Incruse Ellipta (umeclidinium) at room temperature in a dry place away from heat or sunlight. Keep unused inhalers in the original foil pouch.

          • Incruse Ellipta (umeclidinium) expires in 6 weeks after you remove it from the foil tray. Write the expiration ("use by") date on the first blank line on the inhaler.

            • There's a dose counter on the front face of the Incruse Ellipta (umeclidinium) inhaler. It should say "30" for a new inhaler. Use this counter to keep track of when you need to get a refill.

              • You don't need to prime or shake the Incruse Ellipta (umeclidinium) inhaler before using it. Each time you open the cover of the inhaler, you're preparing 1 dose. Only open the cover of the inhaler if you're about to take a dose.

                • When you're ready to take your dose, slide the cover on the Incruse Ellipta (umeclidinium) inhaler until it clicks and hold it in a flat position, like a hamburger. Then, breathe out as long as you can. Then, without blocking the vent, place your lips firmly around the mouthpiece and take a long, steady, and deep breath.

                  • After you inhale from the Incruse Ellipta (umeclidinium) inhaler, try to hold your breath for 3-4 seconds, or for as long as you comfortably can. This allows the medication to reach deep into your lungs.

                    • Never wash the Incruse Ellipta (umeclidinium) inhaler with water or any liquid. Instead, clean the mouthpiece every once in a while by wiping it with a dry cloth. Just make sure you don't get water or moisture on or near the inhaler. Moisture can make the dry powder medication clump together and clog the inhaler.

                      faqs

                      Frequently asked questions about Incruse Ellipta (umeclidinium)

                      Is Incruse Ellipta (umeclidinium) a steroid?
                      No, Incruse Ellipta (umeclidinium) isn't a steroid; it's a long-acting muscarinic antagonist (LAMA) that's a bronchodilator. Both inhaled corticosteroids and LAMAs can be used to help with COPD, but they work in different ways. Inhale corticosteroids help you breathe better by lowering inflammation in the airways, whereas LAMAs do so by relaxing the muscles in your airways. Your pulmonologist might prescribe an inhaled steroid for you to use in addition to Incruse Ellipta (umeclidinium) to help treat COPD.
                      Does Incruse Ellipta (umeclidinium) make you tired?
                      No, Incruse Ellipta (umeclidinium) doesn't typically make you tired. Incruse Ellipta (umeclidinium) can cause certain side effects, such as upper respiratory tract infections and muscle aches, that might make you feel more tired. But tiredness can also be a symptom of worsening COPD. Let your primary care provider know if you're feeling tired. They'll help try to figure out a cause.
                      How long does it take for Incruse Ellipta (umeclidinium) to work?
                      When you first start Incruse Ellipta (umeclidinium), you might feel improvements in your breathing within a day after a dose. If you don't notice improvements to your breathing after using Incruse Ellipta (umeclidinium), your pulmonologist might make changes to your COPD treatment.
                      Can you use Breo Ellipta (fluticasone / vilanterol) and Incruse Ellipta (umeclidinium) together?
                      Yes, Incruse Ellipta (umeclidinium) and Breo Ellipta (fluticasone / vilanterol) can be used together if prescribed by your healthcare team. Incruse Ellipta (umeclidinium) is a long-acting muscarinic antagonist (LAMA), and Breo Ellipta (fluticasone / vilanterol) is an inhaled corticosteroid (ICS) and long acting beta-agonist (LABA). Triple therapy with a LAMA, ICS, and LABA is recommended for certain people who still have severe COPD symptoms even though they're taking Incruse Ellipta (umeclidinium). If you need triple therapy, the same manufacturer who makes Incruse Ellipta and Breo Ellipta also makes Trelegy Ellipta, which contains an ICS (fluticasone), LAMA (umeclidinium), and LABA (vilanterol).
                      Can Incruse Ellipta (umeclidinium) be used for asthma?
                      Incruse Ellipta (umeclidinium) isn't FDA-approved for asthma. But other types of long-acting muscarinic antagonists are approved to help with asthma. Talk with your healthcare team if you have more questions about treatment for asthma.
                      Does Incruse Ellipta (umeclidinium) cause hair loss?
                      No, hair loss wasn't a side effect reported by people using Incruse Ellipta (umeclidinium) in clinical studies. If you notice hair loss while you're taking Incruse Ellipta (umeclidinium), contact your primary care provider so they can help you figure out possible causes.
                      Does Incruse Ellipta (umeclidinium) increase blood pressure?
                      No, Incruse Ellipta (umeclidinium) isn't known to increase (raise) blood pressure. So this medication might be an option for people who have high blood pressure. Talk with your healthcare team if you have more questions about Incruse Ellipta (umeclidinium) and blood pressure.
                      How many puffs are in Incruse Ellipta (umeclidinium) inhaler?
                      Each Incruse Ellipta (umeclidinium) inhaler has 30 doses, which lasts a month. There's a dose counter on the front face of the Incruse Ellipta (umeclidinium) inhaler. It should say "30" for a new inhaler. Use this counter to keep track of when you need to get a refill.
                      GoodRxEducationalIcon

                      How to save using GoodRx

                      Compare Prices
                      1. Compare PricesSpecify your dosage and quantity to find out exactly how much you can save.
                      Select your free coupon
                      2. Select your free couponYou can use the displayed coupon, or compare prices at other pharmacies near you.
                      Show coupon to your pharmacist
                      3. Show coupon to your pharmacistPresent your printed or electronic coupon when you pick up your prescription.
                      Get free couponLearn more
                      warings-icon

                      What are the risks and warnings for Incruse Ellipta (umeclidinium)?

                      Incruse Ellipta (umeclidinium) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.

                      risk-warning

                      Not a rescue inhaler

                      Don't use Incruse Ellipta (umeclidinium) if you're experiencing trouble breathing because this medication won't provide immediate relief. Use a rescue inhaler, such as albuterol (Ventolin HFA), if you're having trouble breathing.

                      If you're using your rescue inhaler more often than usual, let your pulmonologist know because this could be a sign that your condition is getting worse. Don't use more doses Incruse Ellipta (umeclidinium) than recommended because this won't improve your breathing. Rather, this can raise your risk for serious side effects, such as heart problems, tremors, and dizziness.

                      risk-warning

                      Narrowing of your airways (bronchospasm)

                      Inhaled medications, including Incruse Ellipta (umeclidinium), can sometimes cause a muscle spasm in your lungs. This can lead to difficulty breathing, wheezing, cough, and chest discomfort. If you have a hard time breathing after inhaling Incruse Ellipta (umeclidinium), use your rescue inhaler and get medical attention right away.

                      risk-warning

                      Serious allergic reactions

                      • Risk factors: Allergy to milk proteins (lactose)

                        Severe allergic reactions to Incruse Ellipta (umeclidinium) are possible, including life-threatening reactions like facial swelling, shock, and anaphylaxis (closing of the throat). Get medical attention right away if you notice hives, rash, red skin, swelling of the lips or tongue, or difficulty breathing after using Incruse Ellipta (umeclidinium).

                        risk-warning

                        Worsening narrow-angle glaucoma

                        • Risk factors: Long-term use of Incruse Ellipta (umeclidinium) | History of glaucoma | History of high eye pressure

                          Although rare, Incruse Ellipta (umeclidinium) can raise the pressure in your eyes and worsen symptoms of glaucoma. Talk to your optometrist before using Incruse Ellipta (umeclidinium) if you have glaucoma because they might ask you to come in more often for eye exams. Also speak with them if you notice any changes to your vision while using the medication.

                          risk-warning

                          Trouble urinating

                          • Risk factors: Enlarged prostate | Bladder-neck obstruction (blockage)

                            Incruse Ellipta (umeclidinium) should be used cautiously by people who have prostate problems or urinary retention, because it can worsen this condition and lead to difficulty urinating. Contact your prescriber if you notice difficulty urinating while using this medication.

                            dosage

                            Incruse Ellipta (umeclidinium) dosage forms

                            The average cost for 1 inhaler of 30 blisters of 62.5mcg of Incruse Ellipta (umeclidinium) is $358.41 with a free GoodRx coupon. This is 16.19% off the average retail price of $427.66.
                            inhaler
                            Inhaler
                            DosageQuantityPrice as low asPrice per unit
                            30 blisters of 62.5mcg1 inhaler$358.41$358.41

                            Typical dosing for Incruse Ellipta (umeclidinium)

                            Each inhalation of Incruse Ellipta delivers 62.5 mcg of umeclidinium.

                            • Adults: The typical dosing is 1 inhalation by mouth once daily.

                            drug-cost

                            How much does Incruse Ellipta (umeclidinium) cost?

                            To access savings, use a GoodRx coupon and pay just a fraction of the retail price.View prices & coupons
                            contraindications-icon

                            Incruse Ellipta (umeclidinium) contraindications

                            Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Incruse Ellipta (umeclidinium) will not be safe for you to take.
                            • Allergy to lactose or milk proteins

                            alternatives

                            What are alternatives to Incruse Ellipta (umeclidinium)?

                            There are a number of medications that your doctor can prescribe in place of Incruse Ellipta (umeclidinium). Compare a few possible alternatives below.
                            Incruse Ellipta (umeclidinium)
                            Used for:
                            $358.41 Lowest GoodRx priceView Prices
                            Used for:
                            • Chronic obstructive pulmonary disease (COPD)

                            • Asthma in people age 6 years and older - Spiriva Respimat only

                            $126.32 Lowest GoodRx priceView Prices
                            Used for:
                            $345.26 Lowest GoodRx priceView Prices
                            images

                            Incruse Ellipta (umeclidinium) images

                            white - INCRUSE ELLIPTA 62.5mcg / actuation Powder for Inhalation
                            This medicine is White Inhaler.white - INCRUSE ELLIPTA 62.5mcg / actuation Powder for Inhalation

                            Get savings updates for Incruse Ellipta (umeclidinium)

                            Receive price alerts, news, and other messages from GoodRx about Incruse Ellipta (umeclidinium) and other healthcare topics and relevant savings offers.

                            By providing your email, you consent to receive marketing communications from GoodRx, which may include content and/or data related to men’s health, women's health, reproductive care, or sexual health. You agree to the GoodRx Terms of Use and acknowledge the Privacy Policy. You can unsubscribe at any time.

                            References

                            Best studies we found

                            Alagha, K., et al. (2014). Long-acting muscarinic receptor antagonists for the treatment of chronic airway diseases. Therapeutic Advances in Chronic Disease.

                            American Lung Association. (2024). Measuring your peak flow rate.

                            Calverley, P. M. A., et al. (2017). Triple therapy in COPD: What we know and what we don't. Chronic Obstructive Pulmonary Disease.

                            View All References (3)

                            GlaxoSmithKline LLC. (2023). Incruse Ellipta- umeclidinium aerosol, powder [package insert]. DailyMed.

                            Grant, A. C., et al. (2015). The ELLIPTA® dry powder inhaler: Design, functionality, in vitro dosing performance and critical task compliance by patients and caregivers. Journal of Aerosol Medicine and Pulmonary Drug Delivery.

                            Sam, C., et al. (2023). Physiology, acetylcholine. StatPearls.

                            GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.
                            Was this page helpful?

                            Browse medications

                            View All

                            Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.